Novazyme Pharmaceuticals
Oklahoma City
About Novazyme Pharmaceuticals
Novazyme Pharmaceuticals is a biotech startup that conducts research on a new experimental treatment for Pompe disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $5.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2001)
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/novazyme-pharmaceuticals-793395 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.